ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
6,025.99
-0.95%
Dow Jones
44,303.40
-0.99%
US Dollar vs MXN
20.5714
0.00%
Brent Oil
74.565
0.00%
Bitcoin
95,919.10
-0.65%
Pepperstone
Advertisement
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. Oruka Therapeutics Inc (ORKA) Cotización

Oruka Therapeutics Inc

Oruka Therapeutics Inc (ORKA)

NASDAQ
11.40
-1.68
(-12.84%)
Cerrado 08 Febrero 3:00PM
Delayed by 15 minutes
11.50
0.10
(0.88%)
Fuera de horario: 6:59PM
Delayed by 15 minutes

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Estadísticas y detalles clave

Último Precio
11.40
Postura de Compra
10.95
Postura de Venta
11.99
Volume Operado de la Acción
505,987
11.1126 Rango del Día 13.47
10.95 Rango de 52 semanas 31.13
Capitalización de Mercado [m]
398.983M
Precio Anterior
13.08
Precio de Apertura
13.01
Hora
1
@
11.99
Última hora de negociación
Volumen financiero
US$ 6,242,960
Precio Promedio Ponderado
12.3382
Volumen promedio (3 m)
311,590
Acciones en circulación
34,998,550
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-74.43
Beneficio por acción (BPA)
-0.15
turnover
-
Beneficio neto
-5.34M

Acerca de Oruka Therapeutics Inc

ARCA biopharma Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to the development and commercialization of targeted therapies for cardiovascular diseases. The company's product candidates are rNAPc2 as a potential treatment for COVID-19, the disease syndrome ... ARCA biopharma Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to the development and commercialization of targeted therapies for cardiovascular diseases. The company's product candidates are rNAPc2 as a potential treatment for COVID-19, the disease syndrome caused by the SARS-CoV-2 virus, and potentially other viral diseases and Gencaro for the treatment of atrial fibrillation, or AF, in patients with chronic heart failure, or HF. rNAPc2 targets COVID-19 patients with biomarker evidence of coagulopathy, while Gencaro is being developed for patients who have a genotype that identifies a drug target associated with heightened efficacy. Mostrar más

Sector
In Vitro,in Vivo Diagnostics
Industria
In Vitro,in Vivo Diagnostics
Sitio web
www.orukatx.com
Sede
Wilmington, Delaware, USA
Fundado
-
Oruka Therapeutics Inc is listed in the In Vitro,in Vivo Diagnostics sector of the NASDAQ with ticker ORKA. The last closing price for Oruka Therapeutics was US$13.08. Over the last year, Oruka Therapeutics shares have traded in a share price range of US$ 10.95 to US$ 31.13.

Oruka Therapeutics currently has 34,998,550 shares in issue. The market capitalisation of Oruka Therapeutics is US$457.78 million. Oruka Therapeutics has a price to earnings ratio (PE ratio) of -74.43.

ORKA Últimas noticias

Más noticias

Form 8-K - Current report

05 Febrero 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

24 Enero 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

24 Enero 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

24 Enero 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

24 Enero 2025
Edgar (US Regulatory)

Form 8-K - Current report

19 Diciembre 2024
Edgar (US Regulatory)

Oruka Therapeutics Announces First Participants Dosed in Phase 1 Trial of ORKA-001, its Novel Half-life Extended Anti-IL-23p19 Antibody

Pharmacokinetic and safety data from healthy volunteers anticipated in the second half of 2025 On track to initiate a proof-of-concept study in psoriasis in the second half of 2025, with initial...

19 Diciembre 2024
GlobeNewswire Inc.

Oruka Therapeutics to be Added to the Nasdaq Biotechnology Index (NBI)

MENLO PARK, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a biotechnology company developing novel biologics designed to set a new standard for the...

18 Diciembre 2024
GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness

26 Noviembre 2024
Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

21 Noviembre 2024
Edgar (US Regulatory)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-1.145-9.1271422877612.54515.111.3520244213.69303911CS
4-7.32-39.102564102618.7218.76510.9530859913.28034677CS
12-11.65-50.542299349223.0525.6510.9531159018.53213471CS
26-17.6-60.68965517242931.1310.9520561920.42367495CS
52-17.6-60.68965517242931.1310.9520561920.42367495CS
156-17.6-60.68965517242931.1310.9520561920.42367495CS
260-17.6-60.68965517242931.1310.9520561920.42367495CS

ORKA - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Oruka Therapeutics?
El precio actual de las acciones de Oruka Therapeutics es US$ 11.40
¿Cuántas acciones de Oruka Therapeutics están en circulación?
Oruka Therapeutics tiene 34,998,550 acciones en circulación
¿Cuál es la capitalización de mercado de Oruka Therapeutics?
La capitalización de mercado de Oruka Therapeutics es USD 457.78M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Oruka Therapeutics?
Oruka Therapeutics ha negociado en un rango de US$ 10.95 a US$ 31.13 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Oruka Therapeutics?
El ratio precio/beneficio de Oruka Therapeutics es -74.43
¿Cuál es la moneda de reporte de Oruka Therapeutics?
Oruka Therapeutics presenta sus resultados financieros en USD
¿Cuál es el último beneficio anual de Oruka Therapeutics?
El último beneficio anual de Oruka Therapeutics es USD -5.34M
¿Cuál es la dirección registrada de Oruka Therapeutics?
La dirección registrada de Oruka Therapeutics es 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
¿Cuál es la dirección del sitio web de Oruka Therapeutics?
La dirección del sitio web de Oruka Therapeutics es www.orukatx.com
¿En qué sector industrial opera Oruka Therapeutics?
Oruka Therapeutics opera en el sector IN VITRO,IN VIVO DIAGNOSTICS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
MGOLMGO Global Inc
US$ 0.4191
(126.54%)
816.59M
CDTConduit Pharmaceuticals Inc
US$ 2.831
(82.65%)
144.17M
GSIWGarden Stage Ltd
US$ 0.79
(78.73%)
219.64M
TOIIWOncology Institute Inc
US$ 0.033
(58.88%)
7.27k
CYTHCyclo Therapeutics Inc
US$ 1.19
(54.55%)
84.73M
FTELFitell Corporation
US$ 2.70
(-57.01%)
2.3M
SGBXSafe and Green Holdings Corporation
US$ 0.6401
(-44.82%)
5.65M
NKLANikola Corporation
US$ 0.4432
(-41.10%)
52.44M
PLRXPliant Therapeutics Inc
US$ 7.785
(-34.85%)
6.44M
LIPOLipella Pharmaceuticals Inc
US$ 3.08
(-33.76%)
2.2M
MGOLMGO Global Inc
US$ 0.4191
(126.54%)
816.59M
RIMEAlgorhythm Holdings Inc
US$ 0.0169
(-20.66%)
274.2M
NVDANVIDIA Corporation
US$ 129.84
(0.90%)
228.2M
GSIWGarden Stage Ltd
US$ 0.79
(78.73%)
219.64M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.0537
(14.74%)
212.29M

Discusión

Ver feed completo
fourcloze fourcloze 5 minutos hace
lol, orca even looks like an idiot!!
VDRM
glenn1919 glenn1919 6 minutos hace
CYCN................................................https://stockcharts.com/h-sc/ui?s=CYCN&p=W&b=5&g=0&id=p86431144783
CYCN
rainmaker71 rainmaker71 7 minutos hace
NICE ACCUMULATION THIS WEEK AND PPS SUPPORT. YEARLY REPORT DUE BY END OF MARCH AND HOPEFULLY A PR OR 2 WITH SOME REAL NUGGETS AND WE FLY TO .10 RANGE!
VDRM
glenn1919 glenn1919 8 minutos hace
TRVG........................................https://stockcharts.com/h-sc/ui?s=TRVG&p=W&b=5&g=0&id=p86431144783
TRVG
StayHumble StayHumble 9 minutos hace
wow💹60M+ $HIRU XPERT✅BUYS💹✅💹 https://ih.advfn.com/stock-market/USOTC/hiru-pk-HIRU/trades
HIRU
glenn1919 glenn1919 10 minutos hace
HCWB..................https://stockcharts.com/h-sc/ui?s=HCWB&p=W&b=5&g=0&id=p86431144783
HCWB
arachnodude arachnodude 11 minutos hace
It’s government-validated, scientifically backed, and commercially advancing… but no, let’s all believe Slinger’s "spider-ish silk" analysis over the GAO’s official research...

https://investorshub.advfn.com/uimage/uploads/2023/4/19/gmsnqKBLB_GAO_SPIDER_SILK_GRAPHIC.png

KBLB
glenn1919 glenn1919 11 minutos hace
MRSN................................https://stockcharts.com/h-sc/ui?s=MRSN&p=W&b=5&g=0&id=p86431144783
MRSN
KIPK KIPK 12 minutos hace
DRAGON, you look exactly as those who know you would depict you..
POSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSS!!
Congrats...
PHIL
glenn1919 glenn1919 12 minutos hace
MBOT.................................https://stockcharts.com/h-sc/ui?s=MBOT&p=W&b=5&g=0&id=p86431144783
MBOT
weedtrader420 weedtrader420 13 minutos hace
The public all sold their cryptocurrency lmfbo 👋😁
BTCUSD
jammy32 jammy32 14 minutos hace
Problem is elite is not a private company. He could have told us what elite decided not to pay and why. He could have voted on issuing shares to buy out sungen. He could have voted on taking a loan to buy out sungen. Obviously it was a great deal for MIKAH, why not for elite.
ELTP
Torez Torez 14 minutos hace
How you explaine dilution after dilution followed by RS, more dilution another dilution another RS then more dilution all based on zero trucks produced?? Its a FRAUD
NKLA
glenn1919 glenn1919 14 minutos hace
SLRN.................https://stockcharts.com/h-sc/ui?s=SLRN&p=W&b=5&g=0&id=p86431144783
SLRN
StayHumble StayHumble 15 minutos hace
💹Major US Xchange✅$HCWC InfoDeck✅wow https://static1.squarespace.com/static/58a1d7b8893fc0b6d3e47931/t/63599cf2e6708456f8187f4c/1666817273168/HCMC_LDMicroOct2022.pdf

https://investorshub.advfn.com/uimage/uploads/2025/2/4/wsa%5Bxfactsmatterright.png
https:
HCWC
glenn1919 glenn1919 15 minutos hace
FBLG....................https://stockcharts.com/h-sc/ui?s=FBLG&p=W&b=5&g=0&id=p86431144783
FBLG
PickStocks PickStocks 16 minutos hace
You can claim that based on your information you have not been proven wrong......but the ultimate answer to your question is the only way you can be right is if there is a distribution....and so far there has not been a distribution.....the same goes for Cactus and RD.....until then the three of you
COOP
KIPK KIPK 16 minutos hace
STUCKY - Attacking a massively contributing poster, CanItBThisEZ2Make, won't solve your issues...

Those appear to run DEEPER!!!
SRMX
glenn1919 glenn1919 17 minutos hace
CDIO.......................................https://stockcharts.com/h-sc/ui?s=CDIO&p=W&b=5&g=0&id=p86431144783
CDIO
glenn1919 glenn1919 18 minutos hace
FARM.............................https://stockcharts.com/h-sc/ui?s=FARM&p=W&b=5&g=0&id=p86431144783
FARM
MartinLutherKing MartinLutherKing 18 minutos hace
Is it monday yet..News could land on planet earth anytime now …
https://www.tipranks.com/news/ratings/promising-clinical-developments-drive-buy-rating-for-transcode-therapeutics
RNAZ
Jackxkr Jackxkr 18 minutos hace
Don't we have patents issued there.
NWBO
glenn1919 glenn1919 20 minutos hace
BBAI................................https://stockcharts.com/h-sc/ui?s=BBAI&p=W&b=5&g=0&id=p86431144783
BBAI
glenn1919 glenn1919 22 minutos hace
UOKA...................................https://stockcharts.com/h-sc/ui?s=UOKA&p=W&b=5&g=0&id=p86431144783
UOKA
glenn1919 glenn1919 24 minutos hace
PMAX...............................https://stockcharts.com/h-sc/ui?s=PMAX&p=W&b=5&g=0&id=p86431144783
PMAX

Su Consulta Reciente

NASDAQ
ORKA
Oruka Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados

Quitar anuncios

Suscríbete a una experiencia sin publicidad

Sin anuncios

Pruébalo ahora

Mantenga los anuncios